ArticleCureus2025
Elevated Transaminases Revealing Celiac Disease in a Patient With Normal Gastrointestinal Symptoms in a Tertiary Healthcare Setting: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Celiac disease (CD) is a lasting immune disease, most commonly with gastrointestinal symptoms; nonetheless, atypical symptoms of non-digestive tracts have now increasingly become common. We report the case of a 28-year-old woman with a history of constantly increased transaminases and no gastrointestinal symptoms. An extensive hepatic etiology testing was of no note. CD was diagnosed through the presence of positive anti-tissue transglutaminase IgA and duodenal biopsy. There was a great improvement, including liver enzyme normalization, in three months of a gluten-free diet. This case showed the necessity to consider CD as part of the diagnostic process of unexplained hypertransaminasemia despite the lack of gastrointestinal symptoms. Preventive measures of hepatic progression to widespread involvement and an increase in long-term prognosis can be achieved through dietary intervention and early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.